| Value | ₹2,000 Cr |
|---|
NSE filing, NSE: BELRISE. Summary written from the filing by ALFA Finder's alert engine.
Belrise Industries Ltd: key numbers
- Share price
- ₹206.44
- Market cap
- ₹19,966 Cr
- Revenue (annual)
- ₹9,509 Cr
- Net profit (annual)
- ₹496.9 Cr
- P/E (TTM)
- 39.4×Sector 30.5×
- Promoter holding
- 61.15%-5.31% QoQ
- FII holding
- 12.13%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Belrise Industries Ltd
All →Belrise Industries Legal & Regulatory
Belrise Industries received GST order demanding Rs.1,51,026 for FY 2023-24, including tax, interest and penalty. No material operational impact is expected, and an appeal is being evaluated.
- Value
- ₹0.02 Cr
Belrise Industries Other Announcement
Belrise Industries Ltd submitted its quarterly shareholding pattern filing for the period ended September 30, 2026, in compliance with regulatory disclosure requirements.
Belrise Industries Capital Structure Change
Belrise Industries Limited shareholders approved increasing the authorized share capital to Rs. 550 Crore. This change includes an alteration to the Capital Clause of the Memorandum of Association.
Belrise Industries Management Change
Belrise Industries Limited appointed M/s. Shailesh Haribhakti & Associates and M/s. Rathi Rathi and Co. as Joint Statutory Auditors for a five-year term starting FY 2026-27.
- Execution
- 5 years
Belrise Industries Annual General Meeting
Belrise Industries held its 30th Annual General Meeting on September 30, 2026, transacting business including financial statement adoption, dividend declaration, and appointment of auditors.
Belrise Industries Annual General Meeting
Belrise Industries' 30th Annual General Meeting is scheduled for September 30, 2026. The agenda includes final dividend declaration and an increase in authorized share capital.
Other fund raise announcements
All →Sudarshan Pharma Industries Fund Raise of ₹72 Cr
Sudarshan Pharma's board approved up to Rs. 72 Crore of preferential convertible warrants for promoters Hemal and Sachin Mehta. Shareholder approval will be sought at an EGM.
- Value
- ₹72.00 Cr
Flywings Simulator Training Centre Fund Raise of ₹68.2 Cr
Flywings Simulator's board approved Rs. 68.20 Crore fully convertible warrants on a preferential basis. Promoter Rupal Mandavia is allotted Rs. 25 Crore, subject to shareholder approval.
- Value
- ₹68.20 Cr
Kanel Industries Fund Raise of ₹16.99 Cr
Kanel Industries' board approved a rights issue of 42.52 lakh equity shares at Rs.39.95 each. The issue aggregates about Rs.16.99 Crore, with record date 13 November 2026.
- Value
- ₹16.99 Cr
- Execution
- Rights issue opens 23 November 2026 and closes 30 November 2026
Sudarshan Pharma Industries Fund Raise
Board approved issuing up to 72 Crore warrants to promoters on a preferential basis. Pricing per Reg 164 is pending, with no fixed rupee value stated.
GAIL (India) Fund Raise
GAIL Board approved in principle the IPO of subsidiary GAIL Gas Limited on Indian exchanges. GAIL will dilute its GGL equity up to 25%.
Gujarat Inject (Kerala) Fund Raise of ₹3 Cr
Gujarat Inject Kerala's board approved a Rs.3 Crore preferential warrant issue to public investors. Authorised capital will rise to Rs.17.63 Crore, subject to shareholder approval.
- Value
- ₹3.00 Cr